Design
breast cancer
BREAST CANCER
This randomized, controlled trial was conducted at a tertiary public hospital in Xi'an, Shaanxi Province, China. Patients who were diagnosed with breast cancer by pathologic puncture between March 2020 and November 2020 were recruited. Patients were enrolled before surgery. The study protocol was based on the CONSORT 2010 checklist and was registered retrospectively on 